JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2008; 51:690-697, doi:10.1016/j.jacc.2007.10.040
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View CVN News Brief
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Google Scholar
Right arrow Articles by Ndrepepa, G.
Right arrow Articles by Kastrati, A.
PubMed
Right arrow Articles by Ndrepepa, G.
Right arrow Articles by Kastrati, A.
Related Collections
Right arrowRelated Articles

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

Appropriateness of Including Bleeding as a Component of a Quadruple End Point

Gjin Ndrepepa, MD*, Peter B. Berger, MD{dagger}, Julinda Mehilli, MD*, Melchior Seyfarth, MD*, Franz-Josef Neumann, MD{ddagger}, Albert Schömig, MD*,§ and Adnan Kastrati, MD*,*

* Deutsches Herzzentrum, Technische Universität, Munich, Germany
{dagger} Geisinger Clinic, Danville, Pennsylvania
{ddagger} Herz-Zentrum, Bad Krozingen, Germany
§ Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany.

Manuscript received July 31, 2007; revised manuscript received September 21, 2007, accepted October 1, 2007.

* Reprint requests and correspondence: Dr. Adnan Kastrati, Deutsches Herzzentrum, Lazarettstrasse 36, 80636 München, Germany. (Email: kastrati{at}dhm.mhn.de).

Objectives: The aim of the study was to investigate the relationship between bleeding within the 30 days after percutaneous coronary interventions (PCI) and 1-year mortality and to assess the appropriateness of inclusion of the periprocedural bleeding in a quadruple composite end point to assess PCI outcome.

Background: Periprocedural bleeding is one of the most frequent complications of PCI.

Methods: This study included 5,384 patients from 4 randomized placebo-controlled trials on the value of abciximab after pre-treatment with 600 mg of clopidogrel: ISAR-REACT, -SWEET, -SMART-2, and –REACT-2. Bleeding—defined according to the Thrombolysis In Myocardial Infarction criteria—included all bleeding events within 30 days after enrollment. The primary end point was 1-year mortality.

Results: In the 4 trials, within the first 30 days there were 42 deaths (0.8%), 314 myocardial infarctions (MIs) (5.8%), 52 urgent revascularizations (1.0%), and 215 bleeding complications (4.0%). Mortality at 1 year was 3.6% (n = 197). A Cox proportional hazards model revealed that the 30-day occurrence of bleeding (hazard ratio [HR] 2.96, 95% confidence interval [CI] 1.96 to 4.48; p < 0.001), MI (HR 2.29, 95% CI 1.52 to 3.46; p < 0.001) and urgent revascularization (HR 2.49, 95% CI 1.16 to 5.35; p = 0.019) independently predicted 1-year mortality. The c statistic was 0.79 for bleeding, 0.78 for MI, and 0.78 for urgent revascularization, demonstrating a comparable discriminatory power of these adverse events for predicting 1-year mortality.

Conclusions: Our study demonstrates a strong relationship between the 30-day frequency of bleeding and 1-year mortality after PCI and supports the inclusion of periprocedural bleeding in a 30-day quadruple end point for the assessment of outcome after PCI.

Abbreviations and Acronyms
  CI = confidence interval
  HR = hazard ratio
  MI = myocardial infarction
  OR = odds ratio
  PCI = percutaneous coronary intervention


Related Articles

Percutaneous Coronary Intervention Pharmacology: From a Triangle to a Square
Harold L. Dauerman
J. Am. Coll. Cardiol. 2008 51: 698-700. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A35-A36. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Journal Watch CardiologyHome page
Periprocedural Bleeding and Percutaneous Coronary Intervention Outcomes
Journal Watch Cardiology, March 12, 2008; 2008(312): 3 - 3.
[Full Text]


Home page
J Am Coll CardiolHome page
H. L. Dauerman
Percutaneous Coronary Intervention Pharmacology From a Triangle to a Square.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 698 - 700.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2008 by the American College of Cardiology Foundation.